Literature DB >> 16088418

Bilateral coronary artery dilatation and supravalvular pulmonary stenosis in a child with noonan syndrome.

T Uçar1, S Atalay, M Tekin, E Tutar.   

Abstract

Noonan syndrome is the second most frequent congenital malformation syndrome, after Down syndrome, associated with cardiovascular abnormalities. The most prevalent cardiovascular abnormalities in Noonan syndrome are pulmonary stenosis and hypertrophic cardiomyopathy. We report the case of a 12-year-old girl with Noonan syndrome who had multiple cardiovascular abnormalities, including extensive bilateral coronary artery dilatation, valvular and supravalvular pulmonary stenosis, atrial septal defect, and mitral valve prolapse. Both coronary artery dilatation and supravalvular pulmonary stenosis, although rarely reported, are abnormalities of the cardiovascular system that may occur in Noonan syndrome.

Entities:  

Mesh:

Year:  2005        PMID: 16088418     DOI: 10.1007/s00246-005-0935-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  12 in total

1.  Aneurysms of the coronary artery. Report of ten cases and review of literature.

Authors:  A S DAOUD; D PANKIN; H TULGAN; R A FLORENTIN
Journal:  Am J Cardiol       Date:  1963-02       Impact factor: 2.778

2.  Genotype-phenotype correlations in Noonan syndrome.

Authors:  Martin Zenker; Gernot Buheitel; Ralf Rauch; Rainer Koenig; Kirstin Bosse; Wolfram Kress; Hans-Ulrich Tietze; Helmuth-Guenther Doerr; Michael Hofbeck; Helmut Singer; André Reis; Anita Rauch
Journal:  J Pediatr       Date:  2004-03       Impact factor: 4.406

3.  A clinical study of Noonan syndrome.

Authors:  M Sharland; M Burch; W M McKenna; M A Paton
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

4.  [A case of supravalvular pulmonary stenosis associated with Noonan's syndrome: usefulness of Doty's operation].

Authors:  T Sugiura; Y Takahara; Y Sudo; H Murayama; I Nakada; T Sezaki; T Nakamura
Journal:  Kyobu Geka       Date:  1992-05

5.  Lymphstasis in a boy with Noonan syndrome: implication for the development of skeletal features.

Authors:  Tsutomu Ogata; Seiji Sato; Yukihiro Hasegawa; Kenjiro Kosaki
Journal:  Endocr J       Date:  2003-06       Impact factor: 2.349

6.  Congenital coronary artery anomalies in Noonan's syndrome.

Authors:  C K Wong; C H Cheng; C P Lau; W H Leung
Journal:  Am Heart J       Date:  1990-02       Impact factor: 4.749

7.  Congenital localized coronary artery aneurysm without fistula. Report of a preoperatively diagnosed case.

Authors:  G Frithz; I Cullhed; L Björk
Journal:  Am Heart J       Date:  1968-11       Impact factor: 4.749

8.  Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients.

Authors:  M Burch; M Sharland; E Shinebourne; G Smith; M Patton; W McKenna
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

9.  Noonan syndrome associated with anomalous coronary artery and other cardiac defects.

Authors:  Aya Saito; Akihiko Sekiguchi; Masahide Chikada; Kunihiko Tonari
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-01

10.  Hematological findings in Noonan syndrome.

Authors:  Débora R Bertola; Jorge David A Carneiro; Elbio Antônio D'Amico; Chong A Kim; Lilian Maria José Albano; Sofia M M Sugayama; Claudette H Gonzalez
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  2003-04-30
View more
  3 in total

1.  Ectatic coronary arteries in Noonan syndrome.

Authors:  Gurpreet Singh Gulati; Ashish Gupta; Rajnish Juneja; Anita Saxena
Journal:  Tex Heart Inst J       Date:  2011

2.  Development of bilateral coronary artery aneurysms in a child with Noonan syndrome.

Authors:  David M Mauro; Lucia Flors; Andrew W Hoyer; Patrick T Norton; Klaus D Hagspiel
Journal:  Pediatr Radiol       Date:  2015-10-29

Review 3.  Novel insights into an old controversy: is coronary artery ectasia a variant of coronary atherosclerosis?

Authors:  Ertan Yetkin; Johannes Waltenberger
Journal:  Clin Res Cardiol       Date:  2007-04-26       Impact factor: 5.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.